Digital Therapeutics for Mood and Anxiety focuses on software-based interventions with clinical claims—structured CBT/ACT modules, insomnia programs, exposure tools, and therapist-assisted platforms. This page explains what makes a tool a “therapeutic,” how to assess evidence, and how to implement safely in stepped care. If you’re evaluating a digital therapeutics conference, you’ll find formulary criteria, prescribing/onboarding workflows, and integration with measurement-based care. Because sleep is often the first lever, we link to Sleep and Mood Disorders for circadian strategies that amplify digital gains.

Adoption balances access with risk. We outline consent and data governance, equity (language, literacy, disability access), and funding routes. Programs decide where DTx sits—self-guided for mild cases, blended care for moderate, therapist-supervised for complex presentations. Escalation rules trigger human contact on risk or nonresponse; off-ramps stop ineffective use. Dashboards visualize symptom/function change; contracts ensure uptime and security. Staff training and patient education keep expectations realistic—DTx is an adjunct to, not a replacement for, clinical care.